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Background: There is a significant global health burden associated with acute rheumatic fever (ARF) and rheumatic
heart disease (RHD), especially in developing countries. ARF and RHD most often strike children and young adults
living in impoverished settings, where unhygienic conditions and lack of awareness and knowledge of
streptococcal infection progression are common. Secondary prophylactic measures have been recommended in
the past, but primary prevention measures have been gaining more attention from researchers frustrated by the
perpetual prevalence of ARF and RHD in developing countries. Health education aims to empower people to take
responsibility for their own well-being by gaining control over the underlying factors that influence health. We
therefore conducted a review of the current best evidence for the use of health education interventions to increase
awareness and knowledge of streptococcal pharyngitis and ARF.
Methods and design: This article describes the protocol for a systematic review of the effectiveness of health
education interventions aimed at increasing awareness and knowledge of the symptoms, causes and
consequences of streptococcal pharyngitis, rheumatic fever and/or rheumatic heart disease. Studies will be
selected in which the effect of an intervention is compared with either a pre-intervention or a control, targeting all
possible audience types. Primary and secondary outcomes of interest are pre-specified. Randomized controlled
trials, quasi-randomized trials, controlled before–after studies and controlled clinical trials will be considered. We
will search several bibliographic databases (for example, PubMed, EMBASE, World Health Organization Library
databases, Google Scholar) and search sources for gray literature. We will meta-analyze included studies. We will
conduct subgroup analyses according to intervention subtypes: printed versus audiovisual and mass media versus
training workshops.
Discussion: This review will provide evidence for the effectiveness of educational components in health
promotion interventions in raising public awareness in regard to the symptoms, causes and consequences of
streptococcal pharyngitis, ARF and/or RHD. Our results may provide guidance in the development of future
intervention studies and programs.
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Acute rheumatic fever (ARF) is a consequence of inad-
equate treatment of skin or pharyngeal infection with
group A streptococcus (GAS) [1]. ARF requires secondary
prophylaxis of penicillin to prevent recurring episodes, as
well as to prevent the possibility of developing the most
serious consequence of rheumatic heart disease (RHD) [2].
It is estimated that at least 15 million people are currently
living with RHD. Each year approximately 282,000 new* Correspondence: mark.engel@uct.ac.za
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reproduction in any medium, provided the orcases develop and 233, 000 deaths may be attributed to the
disease [3]. ARF and RHD most often strike children and
young adults living in poverty, where overcrowding, under-
nutrition and lack of proper healthcare and awareness of
the disease are common. Approximately 0.5 per 1,000 chil-
dren living in developed countries have RHD, whereas in
sub-Saharan Africa as many as 5 to 7 per 1,000 children
are affected [4].
The World Health Organization (WHO) guidelines
recommend secondary prophylaxis as the most effective
method of reducing the burden of ARF and RHD [1]. Al-
though recent studies have shown that, by the timel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prophylactic measures, they often have already accumu-
lated significant valve damage from unrecognized attacks
of ARF [5].
Primary prevention measures have been gaining more at-
tention from researchers frustrated by the perpetual preva-
lence of ARF and RHD in developing countries around the
globe [6]. Recent investigations have found that primary
prevention is actually more successful and cost-effective [7].
Primary prevention involves a single injection of benzathine
penicillin after confirmation of streptococcal pharyngitis by
microbiological culture of a throat swab specimen. Anti-
biotic treatment of GAS infection has been shown to
reduce the attack of ARF by 70%, with intramuscular peni-
cillin reducing it by as much as 80% [5].
Research has shown that when knowledge of the disease
among a population increases, the number of reported
cases increases and thus the number of patients treated in-
creases [8]. By following The Ottawa Charter for Health
Promotion, established in 1986, health advocates have
made significant strides in treating afflicted populations
around the world [9]. Several strategies promoting the im-
portance of seeking primary prevention treatment (that is,
presenting at a clinic or doctor’s room for a throat swab
evaluation) of streptococcal pharyngitis through education
have been reported [10,11]. These include multifaceted
programs incorporating pamphlets, posters, videos, televi-
sion and radio advertisements, heart models and training
workshops. Previous interventions have targeted various
types of participants, including schoolchildren, parents,
healthcare workers, teachers, community members and
patients. These interventions or multifaceted combina-
tions of interventions may need to be utilized to promote
ARF and RHD awareness and prevention.
Despite the many studies reporting success in health
education interventions to promote awareness of pharyn-
gitis and ARF, a high prevalence of ARF and RHD persists
in many populations [3]. We therefore propose to conduct
a review of the current best evidence for education inter-
ventions to promote awareness of streptococcal pharyn-
gitis and rheumatic fever.Methods and design
The review protocol has not been registered in any pro-
spective register of systematic reviews.Criteria for considering studies for this review
Types of studies
We will include studies that compare the effects of an
intervention with either the pre-intervention findings or a
control. Studies must have been published after 1986, in
accordance with the declaration of the Ottawa Charter.Types of participants
Participants will be schoolchildren, patients, educators or
healthcare workers in school, community, city and nation-
wide settings.Types of interventions
Interventions must include as an objective an educational
aspect of streptococcal pharyngitis, ARF or RHD that con-
tains information relating to symptoms, causes and conse-
quences. We will endeavor to extract the health education
component in instances where interventions are presented
as multifaceted interventions, for example, multimedia or
active surveillance. Should this not be possible, such inter-
ventions will be presented in a narrative fashion.Types of outcome measures
Results must include quantitative data for outcomes
measured.Primary outcomes
The primary outcomes are as follows: increase in throat-
swabbing rates, increase in awareness of ARF and in-
crease in knowledge of symptoms and consequences of
streptococcal pharyngitis, ARF and RHD.Secondary outcomes
The secondary outcomes are increase in the number of
ARF cases reported to hospital or health facilities, de-
crease in the incidence and severity of ARF and RHD,
reduction in the number of recurrent attacks of ARF
and success in regular compliance with secondary
prophylaxis.Search methods for identification of studies
Extensive searches will be performed by LR and LS with
the help of ME to collect all relevant studies available by
May 2013. We will include both peer-reviewed journal arti-
cles and the gray literature in our searches. Only the
English-language literature will be included in the searches.Electronic searches
We will search the following electronic databases:
PubMed, EMBASE, WHO Library databases and Goo-
gle Scholar. We will use both text words and medical
subject heading (MeSH) terms, for example, rheumatic
fever, rheumatic heart disease, streptococcus pyogenes,
GAS, group A strep*, streptococ*, pharyngitis, sore
throat, awareness, health promotion, intervention and
health educat*. These terms will be used in varying
combinations. Table 1 shows the main search strategy
we will use.
Table 1 PubMed search strategy, modified as needed for
use in other databasesa
Search PubMed
1 (awareness) OR (“health promotion”)
OR (intervention) OR (“health educat*”)
2 (“rheumatic fever” [MeSH]) OR
(“rheumatic heart disease” [MeSH]) OR ([tiab])
3 (streptococ*) OR (“group A strept*”)
OR (GAS) OR (“strept* pyogenes”)
4 (“sore throat”) OR (pharyngitis)
OR (“throat infection”)
5 1 AND 2
6 1 AND 3
7 1 AND 4
8 5 AND 6 AND 7
*, wildcard term as per database notation; aMeSH, medical subject heading.
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We will search the following conference proceedings for
relevant abstracts: International Union for Health Promo-
tion and Education, the World Congress of Cardiology,
and the Pan African Society of Cardiology.
Manual searches
We will obtain the reference lists of the selected relevant
studies. The full-text articles analyzed for inclusion in
the review will be evaluated for further information.
Data collection and analysis
The methods for data collection and analysis will be
based on the guidelines of the Cochrane Handbook of
Systematic Reviews for Interventions [12].
Selection of studies
We will construct a screening guide to make certain that
the inclusion criteria are followed and consistently ap-
plied by all review authors. Two review authors (LR and
LS) will work individually to screen the titles and ab-
stracts to determine the eligibility of all studies identified
through the literature searches. LR will obtain the full
text of studies considered potentially eligible. LR and LS
will independently review the full text using inclusion
criteria to evaluate eligibility before comparing results.
Any discrepancies in inclusion or exclusion will be re-
solved through discussion or through consultation with
a third author (ME). Reasons for exclusion will be docu-
mented and reported.
Data extraction and management
References will be managed using Thomson ISI Re-
searchSoft EndNote X2 software (Thomson Reuters,
New York, NY, USA). Two authors will independently ex-
tract data from each included article using a standardizeddata collection form, resolving any incongruities by discus-
sion and agreement. If no consensus can be reached, a
third author (ME) will intercede. LR will enter the final
data into Cochrane Collaboration Review Manager
(RevMan) version 5.1 statistical software (http://ims.
cochrane.org/RevMan). ME will cross-check the entered
data to confirm accuracy.Assessment of risk of bias in included studies
Each included study will be assessed for risk of bias. Two
authors will independently assess the methodological qual-
ity of the studies in accordance with the methods used by
the Cochrane Collaboration [12] and the Cochrane Con-
sumers and Communication Review Group [13]. We will
appraise inter alia the study design, sampling strategy,
method of determining outcomes and appropriateness of
the analytical methods used.
The criteria used to assess the risk of bias for random-
ized controlled trials will include the following elements:
random sequence generation, allocation sequence conceal-
ment, blinding (outcome assessment), incomplete out-
come data, selective outcome reporting and other sources
of bias. Blinding criteria will not be included in the risk of
bias assessment, because blinding of participants and in-
vestigators is not feasible in a health education interven-
tion. If quasi–randomized controlled trials, controlled
before and after studies or interrupted time series studies
are included in the review, we will assess their risk of bias
accordingly, utilizing adaptations to the above criteria by
incorporating suggestions made by the Cochrane Con-
sumer and Communication Review Group [13]. Any dis-
agreements will be resolved by discussion and consensus
in consultation with the third author to resolve persistent
inconsistencies.Measures of treatment effect
Data analysis will be completed using Cochrane Collab-
oration Review Manager version 5.1 statistical software.
For dichotomous data, we will calculate risk ratios and
their corresponding 95% confidence intervals and P
values. For CBA studies, we will report relative post-
intervention percentage changes and standardized mean
differences. We anticipate that data points will primarily be
pre- and post-intervention. Where follow-up data were col-
lected at further follow-up, we will report results taken
from the furthest points in time relative to the intervention.Dealing with missing data
In the cases of absent or incomplete evidence found in
the included studies, study authors will be contacted for
further information.
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heterogeneity
Heterogeneity between trials will be assessed using the χ2
test set at a 10% level of significance. The impact of any
statistical heterogeneity will be quantified using the I2 stat-
istic [12]. If there is an acceptable degree of heterogeneity
and it is appropriate to pool the data, the Mantel-Haenszel
statistical method and random effects analysis model will
be used for analysis. The results will be presented in the
form of a meta-analysis. If we are unable to combine the
studies due to varying study designs or to heterogeneity in
selection of participants, coexisting interventions, attrition
or detection methods, the data will be presented in narra-
tive form. We will perform subgroup analyses by interven-
tion subtypes: printed versus audiovisual and mass media
versus training workshops.Sensitivity analyses
Sensitivity analyses will be performed to determine
whether the study design could influence the results of
the meta-analysis and to determine the impact of ex-
cluding studies with a high-risk bias on the results.
Presenting and reporting of results
Information obtained from this systematic review will be
presented in various ways. The study selection process will
be summarized by means of a flow diagram. The κ statistic
will be used to assess agreement between the full-text
screening, data extraction and risk of bias assessment by
two authors (LR and ME). Summary tables will detail find-
ings and risk-of-bias tables. Forest plots will also be used
where appropriate. Narrative reporting will be used where
outcomes lack quantitative data. Excluded studies with
reasons for exclusion will also be provided.
Discussion
Expected significance of the study
A number of authors have reported that health education
interventions are effective at increasing awareness of dis-
ease control and promoting healthcare-seeking behavior in
populations with ARF and RHD [8,10,14]. Despite this,
there is an incredible lack of knowledge of ARF symptoms
and treatment in developing countries, and thus a high
prevalence of ARF and RHD persists [4]. The findings of
this systematic review will have implications for policy,
practice and research. Our results will provide evidence of
whether educational interventions have a significant effect
on raising public awareness and knowledge regarding
symptoms, causes and consequences of streptococcal pha-
ryngitis and ARF. In addition, we intend to identify ideas or
specific aspects of multifaceted interventions that should be
taken into consideration in future studies, such as the most
effective educational strategy or target population.Abbreviations
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